Global Neurological Drugs Market Growth 2023-2029

Global Neurological Drugs Market Growth 2023-2029

The global Neurological Drugs market size is projected to grow from US$ 115430 million in 2022 to US$ 193720 million in 2029; it is expected to grow at a CAGR of 7.7% from 2023 to 2029.

United States market for Neurological Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Neurological Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Neurological Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Neurological Drugs players cover Pfizer, Ely Lilly, Actavis, Mylan, Randox, Intellipharmaceutics, Astrazeneca, Lundbeck and Allergan, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

Nervous system diseases are diseases that occur in the central nervous system, peripheral nervous system, and autonomic nervous system, mainly manifested in sensory, motor, consciousness, and autonomic dysfunction.

LPI (LP Information)' newest research report, the “Neurological Drugs Industry Forecast” looks at past sales and reviews total world Neurological Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Neurological Drugs sales for 2023 through 2029. With Neurological Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Neurological Drugs industry.

This Insight Report provides a comprehensive analysis of the global Neurological Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Neurological Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Neurological Drugs market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Neurological Drugs and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Neurological Drugs.

This report presents a comprehensive overview, market shares, and growth opportunities of Neurological Drugs market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Non-prescription drugs
Prescription

Segmentation by application
Hospital
Clinic

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Pfizer
Ely Lilly
Actavis
Mylan
Randox
Intellipharmaceutics
Astrazeneca
Lundbeck
Allergan
GSK
Otsuka Pharmaceutical
Takeda
NHU Group
Shionogi
APOTEX
North China Pharmaceutical
Harbin Pharmaceutical Co., Ltd.
Lukang Pharmaceutical
Kelun Pharmaceutical
Kehua Biology

Key Questions Addressed in this Report

What is the 10-year outlook for the global Neurological Drugs market?

What factors are driving Neurological Drugs market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Neurological Drugs market opportunities vary by end market size?

How does Neurological Drugs break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.